Literature DB >> 32713444

Cerebral Autoregulation in Sick Infants: Current Insights.

Elisabeth M W Kooi1, Anne E Richter2.   

Abstract

Cerebrovascular autoregulation is the ability to maintain stable cerebral blood flow within a range of cerebral perfusion pressures. When cerebral perfusion pressure is outside the limits of effective autoregulation, the brain is subjected to hypoperfusion or hyperperfusion, which may cause vascular injury, hemorrhage, and/or hypoxic white matter injury. Infants born preterm, after fetal growth restriction, with congenital heart disease, or with hypoxic-ischemic encephalopathy are susceptible to a failure of cerebral autoregulation. Bedside assessment of cerebrovascular autoregulation would offer the opportunity to prevent brain injury. Clinicians need to know which patient populations and circumstances are associated with impaired/absent cerebral autoregulation.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral autoregulation; Cerebral hemodynamics; Congenital heart disease; Fetal growth restriction; Hypoxic-ischemic encephalopathy; Neonatal surgery; Preterm infant

Year:  2020        PMID: 32713444     DOI: 10.1016/j.clp.2020.05.003

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  2 in total

1.  Cerebral Oxygenation in Preterm Infants Developing Cerebral Lesions.

Authors:  Angelika L Schwab; Benjamin Mayer; Dirk Bassler; Helmut D Hummler; Hans W Fuchs; Manuel B Bryant
Journal:  Front Pediatr       Date:  2022-04-12       Impact factor: 3.418

2.  Correlation between arterial blood pressures and regional cerebral oxygen saturation in preterm neonates during postnatal transition-an observational study.

Authors:  Daniel Pfurtscheller; Christina H Wolfsberger; Nina Höller; Bernhard Schwaberger; Lukas Mileder; Nariae Baik-Schneditz; Berndt Urlesberger; Gerhard Pichler
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.